NCT06526897View on ClinicalTrials.gov

Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma

NANot yet recruitingINTERVENTIONAL
Enrollment

1,582

Participants

Timeline

Start Date

January 28, 2025

Primary Completion Date

November 1, 2032

Study Completion Date

November 1, 2032

Conditions
Adult Pleomorphic RhabdomyosarcomaAJCC Grade 2 SarcomaAJCC Grade 3 SarcomaAlveolar Soft Part SarcomaAngiosarcomaClear Cell Sarcoma of Soft TissueDedifferentiated LiposarcomaExtraskeletal Ewing SarcomaExtraskeletal Myxoid ChondrosarcomaFibrosarcomaFibrosarcomatous Dermatofibrosarcoma ProtuberansLeiomyosarcomaMalignant Peripheral Nerve Sheath TumorMyxofibrosarcomaPleomorphic LiposarcomaRound Cell Sarcoma With EWSR1-non-ETS FusionSarcomaSoft Tissue SarcomaSoft Tissue Sarcoma of the Trunk and ExtremitiesSpindle Cell SarcomaStage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8Synovial SarcomaUndifferentiated Pleomorphic Sarcoma
Interventions
PROCEDURE

Biopsy

Undergo biopsy

PROCEDURE

Chest Computed Tomography

Undergo chest CT

PROCEDURE

Chest Radiography

Undergo CXR

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

ECOG-ACRIN Cancer Research Group

NETWORK